JMP Securities reiterated a Market Outperform rating on Enanta Pharmaceuticals (NASDAQ:ENTA) shares with a consistent price target of $21.00. The firm's analysis highlighted the company's solid ...

JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on KalVista Pharmaceuticals (KALV – Research Report) today and set a price ...

KBC Group NV increased its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report) by 66.2% in the fourth ...

Sambalpur:  IIM Sambalpur, one of the premier management institutions, hosted the much-awaited annual flagship conference titled, "International Management Perspectives Conference (IMPeC) 2025" with ...

Even with its well-documented benefits, DoE is often underutilised, especially for solving specialised or constrained ...

Some people prefer the term “omnisexual” to “pansexual.” That's because the term pansexuality implies that attraction to people has nothing to do with gender. In contrast, people who ...

JMP Securities analyst Constantine Davides raised the firm’s price target on Option Care Health (OPCH) to $35 from $30 and keeps an Outperform ...

JMP Securities updated its outlook on Option Care Health (NASDAQ:OPCH), increasing the price target to $35 from the previous $30, while retaining a Market Outperform rating for the company's stock.

ABSTRACT: The study focuses on the filling of pods from ten cacao clones originating from French Guiana in Côte d’Ivoire. Two reference clones (IFC5 and NA32) were used as controls. The parameters ...

I review privacy tools like hardware security keys, password managers, private messaging apps and ad-blocking software. I also report on online scams and offer advice to families and individuals ...

The dark web isn't something you can just stumble upon, and that's a good thing. Sites on the dark web can contain potentially catastrophic pitfalls in the form of illegal activity, phishing links ...